VLI-03A

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameVLI-03A
Drug Alias NameIBDV-903/78VLI-03AIBDV R903/78HC-001HC-002 +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInflammationAutoimmune DiseasesHepatitis C +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDnatrix IncHep C LtdVectorlogics
China Registration ClassN/A

Develop Information

Active CompaniesHoloclara Aus Pty Ltd
Inactive CompaniesHep C LtdVectorlogicsDnatrix Inc
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A